Aesthetic Industry Leader Brings Nearly Two Decades of Commercial and Marketing Expertise
SAN DIEGO, July 22, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycoproteins, today announced the appointment of Randy W. Kriech as chief commercial officer. In his new role, Mr. Kriech will be responsible for leading global marketing, commercial operations and portfolio management. Mr. Kreich will report to Michael York, chief executive officer, and will be a key member of the Sente, Inc. executive management team.
“Randy is a respected commercial leader in the aesthetic space and we are thrilled to gain his insight and vision to help guide our company and management team,” said Michael York, president and chief executive officer of Sente, Inc. “With his extensive commercial and leadership experience in the aesthetic skincare industry, Randy will be invaluable to Sente as we mature in size and complexity. His unique set of capabilities will enhance our commercial opportunities as we grow our science based skin care product portfolio based on our proprietary formulation of heparan sulfate on a global scale.”
Mr. Kriech brings to Sente, Inc. nearly 20 years of management and commercial experience in the dermatology industry with more than 13 years focused on the development and marketing of aesthetic skincare products. Most recently, Mr. Kriech was Vice President of Sales and Marketing at PrecisionMD, the aesthetic division of Precision Dermatology, where he was responsible for leading worldwide commercialization of the PrecisionMD portfolio. Mr. Kriech has held management roles with a number of companies during their start-up phase within the dermatology marketplace, including SkinMedica and Celfix Cosmeceuticals, in which he was Co-Founder and Owner. Mr. Kriech holds a Bachelor of Arts degree in Communications from the University of Colorado, Boulder.
“Sente has established a strong foundation for commercial success,” said Mr. Kriech, chief commercial officer of Sente, Inc. “I am looking forward to achieving our vision of becoming a recognized leader that brings differentiated new molecules, products and science to fulfill unmet needs in the skincare market.”
About Sente, Inc.
Sente, Inc., a privately held specialty aesthetics company, is a recognized leader in the development of innovative and targeted skincare products utilizing HSA technology, a low molecular weight formulation of heparan sulfate. HSA is essential for skin hydration, rejuvenation and necessary for healthy-looking skin. Sente was founded in 2007 and is based in San Diego, California. Further information may be found at http://sentelabs.com/. Sente products are available through an exclusive network of physicians, medically supervised spas.